Stock Ratings / Health Care / BWAY / earnings

SSII (39) CERS (37) DCTH (57) NPCE (30) ⌘ Pro Terminal →

BrainsWay Ltd. (BWAY) Next Earnings Date & Expected ±7.9% Move

$11.93 +4.93% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $12.01

BrainsWay Ltd. (BWAY) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY) →

ROARABLE C- • HOLD / WATCH Cap $478.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $12.01 (+0.70%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.3% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY • 53.9% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+1.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BWAY)Realized 20D OHLCV Swing Band: ±7.9%

Deterministic 5-Pillar Attribution (61/100 Composite)

🔍 WHY BWAY SCORES 61/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (25% of score)

FRED Regime × Technicals: 47% of 52W Range • RSI-14 at 40.9 (NEUTRAL RANGE)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (21% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$11.77-2.8% Next Q

Q2 (-2Q)

Grade C$11.44-1.7% Next Q

Q3 (-1Q)

Grade C$11.25+6% Next Q

Current

Grade C-$11.93+0.5% Hist 90D α

Trajectory: C- (53) → C- (61)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the BWAY Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 61/100 (C-) score, BWAY faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.95) or 200D SMA ($13.92) invalidates the momentum regime and cuts Target Base ($12.09) toward Bear Floor ($9.43).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BWAY• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BWAY Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 61%NO 39%Trade / Inspect Odds →

NEXT EST. WINDOW: Upcoming Quarter (~28 DAYS)

Historical OHLCV Volatility ±7.9% Swing Band

±$0.94 Expected Swing

MODEL EARNINGS SETUP GAUGE

BWAY Quantitative Pre-Earnings Setup: 61/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (61/100)Model Risk Weight (39/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating BWAY & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on BWAY
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BWAY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -27.96%📐 HORIZONTAL RANGE

2026-10-30O $11.58H $11.93L $11.16C $11.93VOL 123.9K

RES: $17.44SUP: $10.87SMA50: $12.95SMA200: $13.92

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BWAY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BWAY Butterfly Map → + Track BWAY →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BWAY today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BWAY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BWAY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BWAY)

Health Care Rank #190 of 1016 ⚔️ SSII vs BWAY Full Matrix →

1. Head-to-Head Health Care Peer Comparison (BWAY vs. SSII, CERS, DCTH, NPCE)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, BrainsWay Ltd. (BWAY) ranks #190 by composite RQD confidence (61/100, grade C-) and #461 by equity capitalization ($478.7M). Within this direct 5-issuer industry benchmark cohort, BWAY leads on earnings valuation at N/A trailing P/E, while DCTH leads on capital efficiency and profitability with 0.8% ROIC and 86.2% gross margin. BWAY currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BWAY ACTIVE BrainsWay Ltd.	C-	61/100	—	—	—	+4.93%	$478.7M	Benchmark Subject
SSII SS Innovations International Inc.	D-	39/100	—	46.0%	-18.5%	-2.46%	$477.2M	/ssii-vs-bway →
CERS Cerus Corporation	D-	37/100	—	—	-15.5%	+0.83%	$491.7M	/cers-vs-bway →
DCTH Delcath Systems Inc.	D+	57/100	—	86.2%	0.8%	-1.48%	$508.0M	/dcth-vs-bway →
NPCE Neuropace Inc.	E	30/100	—	77.2%	-23.0%	+0.62%	$446.6M	/npce-vs-bway →

2. BWAY Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

BrainsWay Ltd. (BWAY) operates in Medical/Dental Instruments (Health Care) with an equity capitalization of $478.7M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. BWAY Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BWAY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, BrainsWay Ltd. (NASDAQ: BWAY) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $11.93 (+4.93% 1D, market cap $478.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, BWAY ranks #190 in composite RQD confidence.

How does BWAY compare to SSII and CERS in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), BWAY carries a Roarable C- (61/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SSII (SS Innovations International Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -18.5%, cap $477.2M) and CERS (Cerus Corporation) posts a D- grade (37/100 RQD, P/E N/A, ROIC -15.5%, cap $491.7M). Among the 5-stock peer group, BWAY leads on earnings multiple (N/A) while DCTH leads on capital efficiency (0.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BWAY?

For BrainsWay Ltd. (BWAY), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #190 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BWAY trading relative to its 50-day, 200-day, and 52-week technical levels?

BWAY last traded at $11.93 (+4.93% on volume of 121,745 shares), positioning the stock -7.88% below its 50-day simple moving average ($12.95) and -14.30% below its 200-day simple moving average ($13.92). Across its 52-week range of $7.14 to $17.40, BWAY sits at the 46.7% percentile with a 14-day RSI of 40.9 (NEUTRAL RANGE) and an implied next-earnings move of ±7.9% ($10.99 to $12.87).

BWAY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is BWAY's next earnings date?

Based on SEC filing cadence, BrainsWay Ltd. (BWAY)'s next quarterly reporting window is estimated around Upcoming Quarter.

How much is BWAY stock expected to move on earnings?

Volatility modeling currently projects a ±7.9% event move for BWAY, spanning a range between $10.99 and $12.87.

Direct Sub-Reports: BWAY RQD Cockpit BWAY 12M Forecast BWAY Earnings & Move BWAY Dividends & DRIP BWAY Insiders & 13F BWAY Whale Options BWAY Profit Sankey BWAY News & Why